HELIUS MEDICAL TECHNOLOGIES (HSDT) Stock Analyst Ratings
NASDAQ:HSDT - Nasdaq - US42328V8019 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to HSDT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 658.36% above the current price.
HSDT was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about HSDT.
In the previous month the buy percentage consensus was at a similar level.
HSDT was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-16 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-03-05 | Roth MKM | Maintains | Buy -> Buy |
| 2022-12-20 | Maxim Group | Initiate | Buy |
| 2022-08-23 | Roth Capital | Initiate | Buy |
| 2021-11-15 | Noble Capital Markets | Downgrade | Outperform -> Market Perform |
| 2021-03-24 | Noble Capital Markets | Initiate | Outperform |